Dr. Chiu has over twenty years of experience in the life sciences industry as an entrepreneur, researcher, and venture investor. Dr. Chiu is currently a founding and managing partner for CMX Capital, LLC, a San Diego based life science fund that focuses on biotech and pharmaceuticals. In addition Dr. Chiu serves as a consultant CSO, and VP Business Development for Bridgetech Holdings International (OTC, BGTH.PK), a San Diego life science company that seeks to license US biotechnologies, devices, and diagnostics for development and sales in China and Taiwan. Prior to founding CMX Capital Fund, Dr. Chiu founded its predecessor Novel Bioventures Advisors, where he served as Managing Director. He was a Venture Partner at Forward Ventures, where he sourced and evaluated numerous private equity investments and served as either Director or board observer for MedicineNet, Genicon Sciences, Arizeke, and Nereus Biosciences.
Dr. Chiu has both clinical development and marketing experience with several pharmaceuticals from two major pharmaceutical companies, Schering-Plough and Novartis. He was part of the founding oncology team for Novartis Oncology and led the effort to put together the Oncology team’s first sales force and product launch. He has launched products both domestically and internationally including Caelyx/Doxil, a product for treatment of AIDS-related Kaposi’s Sarcoma and other solid tumors; and Sandostatin, a Novartis product for the treatment of Acromegaly and GEP tumors. At Novel Bioventures, Dr. Chiu built the investment team that invested in seven companies in less than two years, including such companies as Cellerant, Transmedics, Predix, ARYx, Omeros, Capnia, and Intrabiotics. In addition Dr. Chiu worked with the investment team to invest in a variety of venture and hedge funds including some of the top life science funds in the business. Dr. Chiu also brings firsthand experience with the company-building process. He founded Atria, an e-health company, over saw its merger with Scibernet and served as its CEO from inception.
Dr. Chiu holds an M.D. from the Stanford University School of Medicine and an M.B.A. from the Haas School of Business at the University of California, Berkeley. He received his B.A. in Biochemistry from Cornell and is a member of the American College of Gastroenterology and the American Association of Clinical Endocrinologists.
